Innovative Growth Model Provides Insights for Hormone Therapy in Children with Short Stature#South_Korea#Daejeon#Chungnam_National_University#Pediatric_Research#Growth_Hormone
Innovative Growth Model Provides Insights for Hormone Therapy in Children with Short Stature
Chungnam National University's new growth model offers personalized predictions for growth hormone therapy effectiveness in children with idiopathic short stature.
third-news.com
October 5, 2026 at 12:56 PM
Innovative Growth Model Provides Insights for Hormone Therapy in Children with Short Stature#South_Korea#Daejeon#Chungnam_National_University#Pediatric_Research#Growth_Hormone
Novo Nordisk's FDA Approval of Sogroya® Expands Treatment Options for Pediatric Growth Disorders#United_States#Novo_Nordisk#Plainsboro#Growth_Hormone#Sogroya®
Novo Nordisk's FDA Approval of Sogroya® Expands Treatment Options for Pediatric Growth Disorders
The FDA has approved Novo Nordisk's Sogroya®, a groundbreaking growth hormone therapy for various pediatric growth disorders, offering once-weekly convenience.
third-news.com
February 27, 2026 at 9:05 PM
Novo Nordisk's FDA Approval of Sogroya® Expands Treatment Options for Pediatric Growth Disorders#United_States#Novo_Nordisk#Plainsboro#Growth_Hormone#Sogroya®
Understanding Pediatric Growth Hormone Deficiency: A Must for Parents#USA#Pediatric_Health#Mission#Growth_Hormone#Childhood_Development
Understanding Pediatric Growth Hormone Deficiency: A Must for Parents
Pediatric growth hormone deficiency (PGHD) affects child development and can lead to serious health implications. This article reveals vital insights for parents.
third-news.com
June 16, 2025 at 4:09 PM
Understanding Pediatric Growth Hormone Deficiency: A Must for Parents#USA#Pediatric_Health#Mission#Growth_Hormone#Childhood_Development
Growth Hormone Deficiency Market Expected to Experience Steady Growth Driven by New Treatments#None#Growth_Hormone#GHD_Treatments#LUM-201
Growth Hormone Deficiency Market Expected to Experience Steady Growth Driven by New Treatments
The growth hormone deficiency market is projected to grow steadily, fueled by new therapies and increasing diagnosis rates for GHD. Innovations like LUM-201 and SCO-240 promise to reshape treatment options.
third-news.com
June 10, 2025 at 9:35 PM
Growth Hormone Deficiency Market Expected to Experience Steady Growth Driven by New Treatments#None#Growth_Hormone#GHD_Treatments#LUM-201
New Treatment SKYTROFA for Pediatric Growth Hormone Deficiency Launched in Australia#Australia#Sydney#Specialised_Therapeutics#SKYTROFA#Growth_Hormone
New Treatment SKYTROFA for Pediatric Growth Hormone Deficiency Launched in Australia
SKYTROFA is now registered in Australia for treating children with growth hormone deficiency. This innovative therapy offers a once-weekly injection option.
third-news.com
May 29, 2025 at 4:09 PM
New Treatment SKYTROFA for Pediatric Growth Hormone Deficiency Launched in Australia#Australia#Sydney#Specialised_Therapeutics#SKYTROFA#Growth_Hormone